There were no significant differences between the expression of either MYC or TRPS1 in BPH, untreated and hormone-refractory carcinomas, suggesting that alterations in the expression of these two genes are not generally involved in the progression of prostate cancer. This evidence concerns the gene TRPS1 and prostate carcinoma.